Organometallics
Article
3JH‑H = 8.9 Hz, 2H), 3.84 (s, 3H), 2.17 (s, 6H), 2.02 (s, 12H), 1.77 (s,
EXPERIMENTAL SECTION
■
4
6H) ppm. 19F NMR (376 MHz, CD2Cl2): δ = −76.92 (q, JF‑F = 9.0
General Information. All operations were performed under an
inert gas atmosphere (N2), either with standard Schlenk techniques or
in a glovebox (LabMaster 130, MBraun, Garching, Germany), unless
stated otherwise. Diethyl ether, n-pentane, CH2Cl2, tetrahydrofuran,
and toluene were dried by a solvent purification system (SPS,
MBraun). All NMR measurements were conducted on a Bruker
Avance III 400 instrument. Chemical shifts are reported in ppm
relative to the solvent signal; coupling constants are listed in Hz. 13C
NMR spectra were measured using broadband decoupling. Single-
crystal X-ray measurements were carried out on a Bruker Kappa
APEXII Duo diffractometer with Mo Kα radiation at the Institute of
Organic Chemistry, University of Stuttgart. Crystal data have been
deposited with the Cambridge Crystallographic Data Centre
Reagents and starting materials were purchased from ABCR
(Karlsruhe, Germany), Alfa Aesar (Karlsruhe, Germany), and Merck
(Munich, Germany) and used as received unless stated otherwise. S1
was dried over CaH2 and distilled under N2. All solvents were
purchased anhydrous and stored over 3 Å molecular sieves. 1,3-
Dimesitylimidazol-2-ylidene,53 S2,21 S3,21 S4,21 S5,21 S6,52 and
Mo151 were synthesized according to the literature.
4
Hz), −78.67 (q, JF‑F = 9.2), −78.93 ppm. 13C NMR (100 MHz,
CD2Cl2): δ = 311.0, 185.6, 162.8, 142.9, 137.7, 135.3, 134.0, 132.3,
130.6, 128.2, 122.80 (q, J = 286.7 Hz), 122.76 (q, J = 286.6 Hz),
113.7, 85.25 (hept, J = 30.1 Hz), 56.2, 21.3, 20.9, 17.6 ppm. Anal.
Calcd (%) for C38H37F15MoN2O6S: C, 44.28; H, 3.62; N, 2.72.
Found: C, 44.29; H, 3.74; N, 2.80.
Mo5. Na[B(Ph)4] (33.1 mg, 0.10 mmol, 1 equiv) was slowly added
to a solution of Mo4 (100 mg, 0.10 mmol) in CH2Cl2 (4 mL), cooled
to −40 °C, and the mixture was stirred for 1 h at room temperature.
The resulting suspension was filtered through a pad of Celite, the
solvent was removed in vacuo, and the oily residue was excessively
coevaporated with n-pentane (10 × 2 mL) and diethyl ether (10 × 2
mL). The residue was washed with n-pentane (2 × 6 mL) and
crystallized from CH2Cl2/n-pentane. The product was isolated in the
1
form of dark red crystals (103 mg, 0.09 mmol, 88%): H NMR (400
MHz, CD2Cl2): δ = 7.32 (s, 8H), 6.95 (m, 8H), 6.84 (s, 4H), 6.82−
6.74 (m, 4H), 6.77−6.70 (m, 4H), 6.67−6.60 (m, 2H), 3.82 (s, 3H),
2.18 (s, 6H), 1.91 (s, 12H), 1.76 (s, 6H) ppm. 19F NMR (376 MHz,
CD2Cl2): δ = −76.93 (q, J = 9.0 Hz), −78.74 (q, J = 9.1 Hz) ppm.
13C NMR (100 MHz, CD2Cl2): δ = 310.7, 185.3, 165.53−163.58
(m), 162.8, 142.9, 137.6, 136.4, 135.1, 133.9, 132.1, 130.6, 127.6,
126.2, 122.8 (q, J = 286.9 Hz), 122.7 (q, J = 286.6 Hz), 122.3, 113.7,
85.31 (hept, J = 29.7 Hz), 56.2, 21.3, 20.9, 17.5 ppm. Anal. Calcd (%)
for C61H57BF12MoN2O3·(CH2Cl2)0.5: C, 59.41; H, 4.70; N, 2.25.
Found: C, 59.62; H, 4.79; N, 2.34.
Mo2. A solution of triflic acid (28 mg, 0.19 mmol) in 2 mL of
toluene:DME (5:1) was cooled to −40 °C and slowly added at −40
°C to Mo1 (150 mg, 0.18 mmol) dissolved in 4 mL of toluene. The
reaction mixture was stirred for 4 h at room temperature; then the
volatiles were removed in vacuo. The residue was coevaporated with
n-pentane (8 × 1 mL) and diethyl ether (8 × 1 mL), washed with n-
pentane (2 × 2 mL), and crystallized from diethyl ether/n-pentane.
The product was isolated in the form of red crystals (92 mg, 0.11
Mo6. A suspension of Na[B(ArF)4] (343 mg, 0.39 mmol, 1 equiv)
in CH2Cl2 (12 mL), cooled to −40 °C, was slowly added to a solution
of Mo4 (400 mg, 0.39 mmol) dissolved in CH2Cl2 (12 mL), and the
resulting mixture was stirred for 1 h at room temperature. Then, the
suspension was filtered through a pad of Celite, the solvent was
removed in vacuo, and the oily residue was excessively coevaporated
with n-pentane (10 × 2 mL) and diethyl ether (10 × 2 mL). The
residue was washed with n-pentane (2 × 6 mL) and crystallized from
CH2Cl2/n-pentane. The product was isolated in the form of dark red
crystals (580 mg, 0.24 mmol, 86%): 1H NMR (400 MHz, CD2Cl2): δ
= 7.84−7.63 (m, 10H), 7.56 (s, 4H), 6.86 (s, 4H), 6.77 (d, 3JH‑H = 9.0
Hz, 2H), 6.65 (d, 3JH‑H = 9.0 Hz, 2H), 3.81 (s, 3H), 2.16 (s, 6H), 2.00
(s, 12H), 1.79 (s, 6H) ppm. 19F NMR (376 MHz, CD2Cl2): δ =
−62.87 (24F), −76.95 (q, 4JF‑F = 8.7 Hz), −78.78 (q, 4JF‑F = 9.0 Hz)
ppm. 13C NMR (100 MHz, CD2Cl2): δ = 311.1, 185.0, 162.5, 162.0,
161.5, 161.0, 142.8, 137.2, 134.8, 134.5, 133.5, 131.5, 130.2, 128.7
(qq, J = 30.8 Hz, 5.7 Hz), 126.7, 126.0, 123.2, 122.3 (q, 1JC‑F = 286.7
1
3
mmol, 64%): H NMR (400 MHz, CDCl3): δ = 7.36 (d, JH‑H = 8.9
Hz, 2H), 6.81 (d, 3JH‑H = 9.0 Hz, 2H), 4.41 (s, 3H), 4.29 (td, 3JH‑H
=
11.4 Hz, 2JH‑H = 3.2 Hz, 1H), 3.91−3.83 (m, 2H), 3.80 (s, 3H), 3.57−
3.51 (m, 1H), 3.37 (s, 3H), 2.02 (s, 3H), 1.97 (s, 3H) ppm; 19F NMR
4
(376 MHz, CDCl3): δ = −76.35 (q, JF‑F = 9.7 Hz, 3F), −76.73 to
4
−76.85 (m, 3F), −77.30 (q, JF‑F = 3.4 Hz, 3F), −77.55 to −77.69
(m, 3F), −77.92 to −78.10 (m, 3F) ppm; 13C NMR (100 MHz,
1
CDCl3): δ = 303.2, 161.3, 136.8, 133.7, 123.7 (q, JC‑F = 287 Hz,
CF3), 123.6 (q, 1JC‑F = 287 Hz, CF3), 123.5 (q, 1JC‑F = 287 Hz, CF3),
123.1 (q, 1JC‑F = 287 Hz, CF3), 119.5 (q, 1JC‑F = 318 Hz, CF3), 113.6,
85.6 (hept., 1JC‑F = 29.4 Hz), 84.5 (hept., 1JC‑F = 29.3 Hz), 76.0, 73.2,
69.4, 59.6, 55.6, 18.9, 18.8 ppm. Anal. Calcd (%) for
C21H23F15MoO8S: C, 30.90; H, 2.84. Found: C, 30.83; H, 2.91.
Mo3. Mo2 (500 mg, 0.61 mmol) was dissolved in 10 mL of THF
and stirred for 1 h at room temperature. All volatiles were removed in
vacuo; the residue was coevaporated with n-pentane (5 × 2 mL) and
diethyl ether (5 × 2 mL) and crystallized from diethyl ether/n-
pentane/CH2Cl2. The product was isolated in the form of red crystals
1
Hz), 122.2 (q, JC‑F = 286.7 Hz), 120.5, 117.46, 113.2, 85.0 (hept,
2JC‑F = 30.3 Hz, C(CF3)2Me), 55.6, 20.7, 20.4, 16.9 ppm. Anal. Calcd
(%) for C69H49BF36MoN2O3: C, 47.50; H, 2.83; N, 1.61. Found: C,
47.54; H, 3.02; N, 1.66.
1
(450 mg, 0.52 mmol, 84%): H NMR (400 MHz, CDCl3): δ = 7.39
3
3
(d, JH‑H = 9.0 Hz, 2H), 6.82 (d, JH‑H = 9.1 Hz, 2H), 4.62 (s, 2H),
4.37 (s, 2H), 3.80 (s, 3H), 3.76−3.71 (m, 4H), 2.13−2.05 (m, 4H),
1.99 (s, 3H), 1.90 (s, 3H), 1.82−1.77 (m, 4H) ppm. 19F NMR (376
MHz, CDCl3): δ = −77.16 to −77.48 (m, 9F), −77.54 to −77.94 (m,
6F) ppm. 13C NMR (100 MHz, CD2Cl2): δ = 304.7, 161.8, 137. 7,
134.3, 124.23 (q, J = 287.7 Hz), 123.99 (q, J = 287.2 Hz), 123.86 (q, J
= 287.4 Hz), 120.07 (q, J = 317.5 Hz), 113.8, 86.20 (hept, J = 28.4
Hz), 84.84 (hept, J = 28.2 Hz), 79.9, 69.2, 56.0, 26.5, 25.8, 19.7, 19.1
ppm. Anal. Calcd (%) for C25H29F15MoO8S: C, 34.49; H, 3.36.
Found: C, 34.15; H, 3.41.
ASSOCIATED CONTENT
■
sı
* Supporting Information
The Supporting Information is available free of charge at
Detailed experimental procedures, NMR data and
spectra for all compounds (PDF)
Mo4. A cold (−40 °C) solution of 1,3-dimesitylimidazol-2-ylidene
(139.9 mg, 0.46 mmol, 1 equiv) in toluene (50 mL) was added to a
solution of Mo3 (400 mg, 0.46 mmol) in toluene (50 mL), cooled to
−40 °C. The reaction was stirred for 3 h; then the solvent was
removed in vacuo and the residue was coevaporated with n-pentane (5
× 4 mL) and diethyl ether (5 × 4 mL). The resulting solid residue
was washed with n-pentane (3 × 10 mL) and crystallized from diethyl
ether/n-pentane. The product was isolated in the form of orange
crystals (405 mg, 0.39 mmol, 86%): 1H NMR (400 MHz, CD2Cl2): δ
Accession Codes
crystallographic data for this paper. These data can be obtained
Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
3
= 7.95 (s, 2H), 6.86 (s, 4H), 6.77 (d, JH‑H = 9.0 Hz, 2H), 6.66 (d,
1182
Organometallics 2021, 40, 1178−1184